152 related articles for article (PubMed ID: 12103354)
1. The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection.
Lehner T
Trends Immunol; 2002 Jul; 23(7):347-51. PubMed ID: 12103354
[No Abstract] [Full Text] [Related]
2. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.
Montefiori DC; Collman RG; Fouts TR; Zhou JY; Bilska M; Hoxie JA; Moore JP; Bolognesi DP
J Virol; 1998 Mar; 72(3):1886-93. PubMed ID: 9499040
[TBL] [Abstract][Full Text] [Related]
3. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
[TBL] [Abstract][Full Text] [Related]
4. HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production.
Fowke KR; Dong T; Rowland-Jones SL; Oyugi J; Rutherford WJ; Kimani J; Krausa P; Bwayo J; Simonsen JN; Shearer GM; Plummer FA
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1521-30. PubMed ID: 9840285
[TBL] [Abstract][Full Text] [Related]
5. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
[TBL] [Abstract][Full Text] [Related]
6. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
[TBL] [Abstract][Full Text] [Related]
7. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis.
Hecht I; Cahalon L; Hershkoviz R; Lahat A; Franitza S; Lider O
Int Immunol; 2003 Jan; 15(1):29-38. PubMed ID: 12502723
[TBL] [Abstract][Full Text] [Related]
8. CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo.
Bhattacharya J; Peters PJ; Clapham PR
AIDS; 2003; 17 Suppl 4():S35-43. PubMed ID: 15080178
[No Abstract] [Full Text] [Related]
9. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.
Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D
J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220
[TBL] [Abstract][Full Text] [Related]
10. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
[TBL] [Abstract][Full Text] [Related]
11. Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women.
Mnqonywa N; Abbai N; Ragupathy V; Ramjee G; Hewlett I; Moodley D
BMC Res Notes; 2019 Nov; 12(1):745. PubMed ID: 31730016
[TBL] [Abstract][Full Text] [Related]
12. The role of immunity in protection from mucosal SIV infection in macaques.
Bergmeier LA; Wang Y; Lehner T
Oral Dis; 2002; 8 Suppl 2():63-8. PubMed ID: 12164663
[TBL] [Abstract][Full Text] [Related]
13. Preferential targeting of CD4-CCR5 complexes with bifunctional inhibitors: a novel approach to block HIV-1 infection.
Mack M; Pfirstinger J; Haas J; Nelson PJ; Kufer P; Riethmüller G; Schlöndorff D
J Immunol; 2005 Dec; 175(11):7586-93. PubMed ID: 16301668
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
[TBL] [Abstract][Full Text] [Related]
15. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
16. Blockade of HIV-1 infection of New World monkey cells occurs primarily at the stage of virus entry.
LaBonte JA; Babcock GJ; Patel T; Sodroski J
J Exp Med; 2002 Aug; 196(4):431-45. PubMed ID: 12186836
[TBL] [Abstract][Full Text] [Related]
17. A decline in CCL3-5 chemokine gene expression during primary simian-human immunodeficiency virus infection.
Zhao W; Pahar B; Borda JT; Alvarez X; Sestak K
PLoS One; 2007 Aug; 2(8):e726. PubMed ID: 17684570
[TBL] [Abstract][Full Text] [Related]
18. Control of HIV-1 infection by soluble factors of the immune response.
DeVico AL; Gallo RC
Nat Rev Microbiol; 2004 May; 2(5):401-13. PubMed ID: 15100693
[No Abstract] [Full Text] [Related]
19. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
20. Innate immune system damage in human immunodeficiency virus type 1 infection. Implications for acquired immunity and vaccine design.
Howie S; Ramage R; Hewson T
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 2):S141-5. PubMed ID: 11029383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
